Patient engagement in The Metastatic Breast Cancer Project

Liquid biopsy may help guide treatment decisions for advanced solid tumours

Innovative direct-to-patient outreach may accelerate breast cancer research

Liquid biopsy may help guide treatment decisions for advanced solid tumours

First outcome results from MINDACT breast cancer clinical trial

Genetics may influence risk for breast cancer after chest radiotherapy to treat childhood cancer

A presurgery combination therapy may improve outcomes for women with Her2-positive breast cancer

Direct activation of STING in the tumour microenvironment leads to potent and systemic tumour regression and immunity

Successes and challenges in designing combination immunotherapy clinical trials for breast cancer

Understanding personalised medicine - the e-learning course

Breast cancer risk prediction models improved by adding multiple biological markers of risk

Combination therapy before surgery improves outcomes for patients with HER2 positive breast cancer